The document discusses ethical and unethical practices in the Pakistan pharmaceutical market. It notes that the market is worth $6.4 billion and growing at 12% annually. It outlines ethical practices like providing educational information to doctors, limited sponsorship of scientific events, and small promotional gifts. Unethical practices include bribery, paying bills/salaries, lavish gifts/trips, and renovating clinics to incentivize prescribing certain drugs. The document emphasizes ethical promotion helps ensure access to information and medicines for patients.